PioneerGenomic is a sub-category of knowledge-based companies that, with the cooperation of a team of the best specialists, has taken steps towards localization and scientific, technological, and commercial advancement and has made unparalleled progress in the fields of bioinformatics, artificial intelligence, biotechnology, and gene therapy. , stem cells, genomics, biotechnology and personalized medicine and cancer. This company was established with the aim of producing knowledge and providing genetic testing services according to the most up-to-date methods in the world (third generation sequencing) and setting up a genetic scientific-research center (R&D)
Human leukocyte antigen (HLA) typing is used to match patients and donors for bone marrow or cord blood transplants. A close match between a donor’s and a patient’s HLA markers is essential for a successful transplant outcome. This test at PioneerGenomic is the NGS-based high resolution high throughput HLA typing for stem cells donors bank.
After donor and recipient are matched, it is mandatory to confirm the HLA types with a High-resolution methodology and ruling out CWD Null alleles. PioneerGenomic uses NGS technology for this test to reduce the level of ambiguities and is designed based on EFI and ASHI standards.
